Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Cathal A Cadogan

Datos Biográficos

ID8979426
NOMBRECathal A Cadogan
NOMBRESCathal A
APELLIDOCadogan
FIRMACADOGAN C A
AFILIACIONESTrinity College Dublin
ORCID0000-0002-8778-0112
VERIFICADOSí
TOTAL DE OBRAS5
TOTAL DE CITAS0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2018
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0
  • ‘I Wish It Were More Often Told to People Before They Are Prescribed These Medications How Hard It Is to Get Off Them’

    Open Access•Miriam Boland, Allen Higgins et al.•ARTICLE•Health Expectations•2025

    INTRODUCTION: Despite significant increases in the prescribing of psychiatric medication in recent years, many uncertainties exist regarding the process of reducing and stopping these medications. A James Lind Alliance Priority Setting Partnership (PSP) study was conducted to identify the top 10 research priorities on reducing and stopping psychiatric medication. As part of the PSP study, an online survey was conducted, which asked respondents to…

  • ‘We need more support and doctors that understand the process of tapering …’

    Open Access•Tom Lynch, Cristín Ryan et al.•ARTICLE•Health Expectations•2024

    BACKGROUND: Many individuals worldwide continue to take benzodiazepine receptor agonists (BZRAs) long term (≥3 months). The aim of this study was to conduct a content analysis of the views and experiences of discontinuing long-term BZRA use as documented in the free-text responses of respondents to an online questionnaire examining mediators of behaviour change relating to the discontinuation of long-term BZRA use. DESIGN: The questionnaire was d…

  • Supporting safe and gradual reduction of long‐term benzodiazepine receptor agonist use

    Open Access•Tom Lynch, Cristín Ryan et al.•ARTICLE•Health Expectations•2022

    INTRODUCTION: Long-term benzodiazepine receptor agonist (BZRA) use persists in healthcare settings worldwide and poses risks of patient harm. OBJECTIVE: This study aimed to develop an intervention to support discontinuation of long-term BZRA use among willing individuals. METHODS: The intervention development process aligned with the UK Medical Research Council's complex intervention framework. This involved a previous systematic review of brief …

  • ‘I just thought that it was such an impossible thing’

    Open Access•Tom Lynch, Cristín Ryan et al.•ARTICLE•Health Expectations•2022

    INTRODUCTION: Existing interventions to reduce long-term benzodiazepine receptor agonist (BZRA) use lack theoretical underpinning and detailed descriptions. This creates difficulties in understanding how interventions work and how to replicate them in practice. The Theoretical Domains Framework (TDF) can be used to identify behaviour change determinants to target during intervention development. OBJECTIVE: To explore barriers and facilitators to …

  • Improving adherence to multiple medications in older people in primary care

    Open Access•Deborah E Patton, Cathal A Cadogan et al.•ARTICLE•Health Expectations•2018

    BACKGROUND: Medication adherence is vital to ensuring optimal patient outcomes, particularly amongst multimorbid older people prescribed multiple medications. Interventions targeting adherence often lack a theoretical underpinning and this may impact on effectiveness. The theoretical domains framework (TDF) of behaviour can aid intervention development by systematically identifying key determinants of medication adherence. OBJECTIVES: This study …

Sin obras prominentes en esta página.

  • Improving adherence to multiple medications in older people in primary care

    Open Access•Deborah E Patton, Cathal A Cadogan et al.•ARTICLE•Health Expectations•2018

    BACKGROUND: Medication adherence is vital to ensuring optimal patient outcomes, particularly amongst multimorbid older people prescribed multiple medications. Interventions targeting adherence often lack a theoretical underpinning and this may impact on effectiveness. The theoretical domains framework (TDF) of behaviour can aid intervention development by systematically identifying key determinants of medication adherence. OBJECTIVES: This study …

  • Supporting safe and gradual reduction of long‐term benzodiazepine receptor agonist use

    Open Access•Tom Lynch, Cristín Ryan et al.•ARTICLE•Health Expectations•2022

    INTRODUCTION: Long-term benzodiazepine receptor agonist (BZRA) use persists in healthcare settings worldwide and poses risks of patient harm. OBJECTIVE: This study aimed to develop an intervention to support discontinuation of long-term BZRA use among willing individuals. METHODS: The intervention development process aligned with the UK Medical Research Council's complex intervention framework. This involved a previous systematic review of brief …

  • ‘I just thought that it was such an impossible thing’

    Open Access•Tom Lynch, Cristín Ryan et al.•ARTICLE•Health Expectations•2022

    INTRODUCTION: Existing interventions to reduce long-term benzodiazepine receptor agonist (BZRA) use lack theoretical underpinning and detailed descriptions. This creates difficulties in understanding how interventions work and how to replicate them in practice. The Theoretical Domains Framework (TDF) can be used to identify behaviour change determinants to target during intervention development. OBJECTIVE: To explore barriers and facilitators to …

  • ‘We need more support and doctors that understand the process of tapering …’

    Open Access•Tom Lynch, Cristín Ryan et al.•ARTICLE•Health Expectations•2024

    BACKGROUND: Many individuals worldwide continue to take benzodiazepine receptor agonists (BZRAs) long term (≥3 months). The aim of this study was to conduct a content analysis of the views and experiences of discontinuing long-term BZRA use as documented in the free-text responses of respondents to an online questionnaire examining mediators of behaviour change relating to the discontinuation of long-term BZRA use. DESIGN: The questionnaire was d…

  • ‘I Wish It Were More Often Told to People Before They Are Prescribed These Medications How Hard It Is to Get Off Them’

    Open Access•Miriam Boland, Allen Higgins et al.•ARTICLE•Health Expectations•2025

    INTRODUCTION: Despite significant increases in the prescribing of psychiatric medication in recent years, many uncertainties exist regarding the process of reducing and stopping these medications. A James Lind Alliance Priority Setting Partnership (PSP) study was conducted to identify the top 10 research priorities on reducing and stopping psychiatric medication. As part of the PSP study, an online survey was conducted, which asked respondents to…

Medicine (5 obras) · Psychology (5 obras) · Sleep and related disorders (3 obras) · Benzodiazepine (2 obras) · Computer Science (2 obras) · Internal Medicine (2 obras) · Mental Health Treatment and Access (2 obras) · Nursing (2 obras) · Psychiatry (2 obras) · Psychological intervention (2 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae